SPP1 and cancer: OPN overexpression is closely associated with the development of cancer progression, including proliferation, metastasis, angiogenesis, apoptosis resistance, drug resistance, and immunosuppression, and may also be an independent prognostic biomarker for a variety of cancers [10,11].